Epoprostenol Sodium
Overview
Epoprostenol Sodium is a potent vasodilator and inhibitor of platelet aggregation, used predominantly in the treatment of pulmonary arterial hypertension. It mimics the effects of endogenous prostacyclin, improving blood flow and reducing blood pressure in the lungs.
API suppliers (4)
Suppliers of Epoprostenol Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
2 of 4 hold a GMP certificate on record in the EU or UK registers
- CAYMAN PHARMA SROCzechia1 active DMF GMP on record
- Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
- JOHNSON MATTHEY PHARMA SERVICES
- EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan
Therapeutic areas
Do you supply Epoprostenol Sodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.